CollabRx and Cartagenia Partner in Interpretation Support

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CollabRx and Cartagenia Partner in Interpretation Support and Reporting of Genetic Sequencing-Based Tests for Cancer

SAN FRANCISCO, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX) today announced a partnership with Cartagenia, Inc. to provide and promote to the clinical laboratory market an end-to-end software solution to support clinicians and pathologists with clinical genetic testing and reporting in oncology, including next-generation sequencing (NGS) -based tests. Cartagenia is a leader in providing genetics labs and clinicians with software-based workflow support for variant assessment support, lab reporting, and integration of clinical knowledge-bases. Combined with CollabRx's industry-leading decision support solutions in oncology, the partnership will enable clinical and pathology laboratories to generate automated workflows allowing them to quickly and efficiently analyze and report on NGS test results in cancer by providing integrated access to CollabRx's highly credible medical and scientific knowledge with their own proprietary information to create physician- ready reports.

Under terms of the agreement, CollabRx's Genetic Variant Annotation (GVA) Service™ will be integrated with Cartagenia's Bench for Oncology software platform. This capability will allow clinical laboratories to keep up with the scale and pace of change in medical and scientific knowledge associated with NGS cancer panels and use this knowledge to support ordering physicians in patient treatment planning by providing clear and easy-to-understand reports that associate genetic alterations with therapy options. CollabRx and Cartagenia will promote the partnership by cooperating on marketing-related initiatives with the goal of increasing customer recognition of the benefits and advantages of the joint use of each company's products.

"CollabRx's scientists and physicians, together with their large network of clinical advisors, have thought deeply about curating and annotating medical genomics knowledge to support decision making by physicians who wish to consider a tumor's genetic profile in optimizing a treatment plan for their cancer patients," said Steven Van Vooren, one of Cartagenia's scientific founders. "This careful consideration is necessary given the complexity and fast-changing nature of medical and scientific research in cancer genomics. We are highly enthusiastic about working with CollabRx to enable clinical laboratories to access the CollabRx GVA Service through Cartagenia's Bench for Oncology software platform."

"Cartagenia has developed an industry-leading software platform that has been adopted by leading clinical laboratories that value automation in report generation in combination with tools that allow them to access, review and validate high quality knowledge to support the interpretation of results of NGS-based tests in cancer," said Thomas Mika, Chairman, President and CEO of CollabRx. "We are excited to partner with Cartagenia to provide a robust, integrated medical informatics solution to the clinical laboratory market in the U.S. and Europe."

CollabRx and Cartagenia representatives will be available to discuss this partnership at the 2014 Association for Molecular Pathology (AMP) Annual Meeting taking place November 12-15, 2014 in National Harbor, MD.

About CollabRx

CollabRx, Inc. (NASDAQ: CLRX) is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts, starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com .

About the CollabRx GVA Service

The GVA Service offered by CollabRx is a widely used, highly scalable, and cloud-based electronic decision support system that provides a turn-key analysis of many types of genetic alterations in cancer. The GVA Service accepts genetic data from any source or platform and pairs it with information contained in a knowledge base that includes the clinical impact of specific genetic profiles. The CollabRx knowledge base is supported by a proprietary technology platform and expert system that leverages a large and growing network of over 75 thought-leaders and clinical practitioners in the United States and Europe who work together with CollabRx to develop new tools for clinical decision-making in oncology. The GVA Service is offered to customers in a Software as a Service (SaaS) business model.

About Cartagenia

Cartagenia supplies diagnostic support software, database systems, and related services to genetic labs and clinicians, enabling them to perform clinically relevant genetic analyses quickly and efficiently, and offer patients and carers high-quality genetic interpretation and counselling. Cartagenia Bench Lab allows automation of variant assessment protocols and lab report generation for structural and molecular variant assays such as Arrays, Sanger and Next Generation Sequencing. It supports communication with referring physicians, allows labs and clinicians to put variants in their clinical context, and supports confident data sharing. The Cartagenia Bench platform is built in collaboration with genetics labs and clinical experts involved in routine medical practice. Because of this, Bench Lab addresses the specific needs of genetic diagnostic labs and clinicians. Cartagenia Bench is built using a certified ISO13485 Quality Management System and is registered with the FDA as an exempt Class I Medical Device in the United States and as a Class I Medical Device in Europe in conformity with the essential requirements and provisions of the Council Directive 93/42/EEC concerning medical devices, and with the relevant harmonized standards EN ISO62304.

CollabRx Safe Harbor Statement

This press release includes forward-looking statements about CollabRx's anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and CollabRx's plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by CollabRx with the Securities and Exchange Commission. CollabRx undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

CollabRx Contacts:
Gavin J. Gordon, MBA, PhD
Vice President of Business Development & Strategic Alliances
CollabRx, Inc.
ggordon(at)collabrx(dot)com
415-248-5350

Dian Griesel Int'l.
Laura Radocaj- media
lradocaj(at)dgicomm(dot)com
212- 825-3210

Cheryl Schneider- investors
cschneider(at)dgicomm(dot)com
212-825-3210

Cartagenia Contacts
Herman Verrelst
CEO Cartagenia
+32 16 40 40 66
press(at)cartagenia(dot)com
http://www.cartagenia.com

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/11/prweb12312755.htm

CollabRx, Inc. Gavin Gordon +1 415-248-5350

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sokin’s UAE License Turns Expansion Into Real Payments Plumbing

Updated Category News Views 97

Dubai expansion headlines are cheap; regulated local money movement is not. That is why Sokin’s newly approved Dubai Financial Services Authority license deserves more than the usual fintech applause line. The company has paired that approval with AED accounts, local payment rails, a One Za’abeel office and a plan to double its UAE staff over the next year. None of...

Continue Reading
Marelli’s Two Awards Put Practical Auto Tech in Focus

Updated Category News Views 43

Two trophies in Novi do not fill an order book, but Marelli’s latest pair says something useful about where automotive suppliers are trying to earn their keep. The company collected a 2026 Automotive News PACE Award for HorizonView and a PACE Pilot Award for Affordable 5G RedCap at the November 17 ceremony. One is already deployed in production; the other is a...

Continue Reading
LONGi's Solar-Storage Push Faces Africa's Cost Wall

Updated Category News Views 75

A vaccine refrigerator humming through a blackout is more meaningful than another climate-conference slogan. That was the useful thread running through LONGi's November 13 COP31 side event in Antalya, Türkiye: solar and storage are not merely hardware for remote communities. When designed, financed and maintained properly, they can keep clinics, water pumps and other...

Continue Reading
Sysco's Northern California Labor Deal Gets Bigger

Updated Category News Views 0

One hundred forty-four drivers may not rattle a giant food distributor by themselves, but labor agreements have a habit of growing legs. Sysco's Northern California and Nevada regional contract has added members from Teamsters Locals 386 and 431, bringing its coverage above 1,100 workers. For investors watching Sysco, this is less about one afternoon's headline and more...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 116

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Precision Metal Forming Is Industry's Quiet Backbone

Updated Category News Views 72

A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...

Continue Reading
Envision and Tai Tam Put 45 MW Wind Bet to Work in Vietnam

Updated Category News Views 177

A wind site averaging 6.5 meters per second can look unremarkable on a map, yet that is precisely where equipment choices start separating serious developers from brochure merchants. Envision Energy and Vietnam's Tai Tam Group are taking that test on with the 45 MW Phuoc Dan wind project in Khanh Hoa Province. The arrangement follows five years of cooperation, but the...

Continue Reading
Three Cash Buyouts Draw Fresh Shareholder Scrutiny

Updated Category News Views 149

Three cash-price tags landed on the tape with a lawyerly asterisk attached: are public holders actually getting a fair shake? On November 18, 2026, Halper Sadeh LLC said it was investigating proposed sales involving Surgery Partners, Braze and CCC Intelligent Solutions. That is not a finding of misconduct, and investors ought to keep that distinction bolted firmly to the...

Continue Reading
Marina del Rey's Travel Award Brings Fresh Attention

Updated Category News Views 39

A harbor town just got handed a useful little megaphone. On November 18, 2026, the Marina del Rey Tourism Board said Marina del Rey had been selected as a winner in Good Housekeeping's 2027 Travel Awards. That is not a quarterly earnings event, and nobody ought to dress it up as one. Still, in the visitor economy, recognition from a broad consumer publication can matter...

Continue Reading
Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 34

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading

Top 5 Most Recently Viewed Articles

Tecsys Applauds 2026 Supply Chain Trailblazers

Updated Category News Views 26

Celebrating Supply Chain Game-Changers Diving headfirst into the world of supply chains at Tecsys's signature event, the User Conference in Nashville, showcased this year's champions who took the bull by the horns. These aren’t mere button pushers. They’re the powerhouses of healthcare and distribution, pushing operational performance to new heights. Driving Supply...

Continue Reading
Key Insights on Icelandic Salmon's Upcoming Q2 Results Webinar

Updated Category News Views 129

Exciting Presentation of Icelandic Salmon's Q2 Results Icelandic Salmon is gearing up to unveil its second quarter results for 2025. This exciting upcoming event is slated to take place on a Thursday via a Teams webinar, providing a platform for a detailed overview of the company's performance. Details of the Presentation Hosted by the esteemed CEO Bjørn Hembre alongside...

Continue Reading
TRG Screen Launches Xmon AI Assist for Enhanced Data Insights

Updated Category News Views 225

Revolutionizing Data Management with AI Technology In today's fast-paced financial landscape, organizations are constantly seeking tools that streamline operations and enhance decision-making capabilities. TRG Screen has risen to the occasion with the introduction of Xmon AI Assist, a cutting-edge innovation designed to transform how financial institutions manage their...

Continue Reading
Crypto Analyst Raoul Pal Discusses the Current Banana Zone Trends

Updated Category News Views 379

Raoul Pal’s Insights on the Current Crypto Market U.Today - Raoul Pal, the founder and CEO of Real Vision, is widely recognized for his expertise in cryptocurrency and investing. Recently, he took to the social media platform X (formerly known as Twitter) to engage with his followers about the prevailing conditions in the crypto market and the future outlook for...

Continue Reading
Investing $1000 in Gold Fields: A 5-Year Growth Journey

Updated Category News Views 230

The Incredible Return on Gold Fields Investment Gold Fields (NYSE: GFI) has remarkably outperformed the market in the past five years, showcasing an annualized return of 27.98%—a substantial difference over standard investment returns. With a current market capitalization of $38.14 billion, Gold Fields stands out as a worthwhile investment opportunity. What If You...

Continue Reading